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ABSTRACT
Deciphering the structure of gene regulatory
networks across the tree of life remains one of the
major challenges in postgenomic biology. We
present a novel ChIP-seq workflow for the archaea
using the model organism Halobacterium salinarum
sp. NRC-1 and demonstrate its application for
mapping the genome-wide binding sites of natively
expressed transcription factors. This end-to-end
pipeline is the first protocol for ChIP-seq in
archaea, with methods and tools for each stage
from gene tagging to data analysis and biological
discovery. Genome-wide binding sites for transcrip-
tion factors with many binding sites (TfbD)
are identified with sensitivity, while retaining speci-
ficity in the identification the smaller regulons
(bacteriorhodopsin-activator protein). Chromosomal
tagging of target proteins with a compact epitope
facilitates a standardized and cost-effective
workflow that is compatible with high-throughput
immunoprecipitation of natively expressed tran-
scription factors. The Pique package, an open-
source bioinformatics method, is presented for
identification of binding events. Relative to ChIP-
Chip and qPCR, this workflow offers a robust
catalog of protein–DNA binding events with
improved spatial resolution and significantly
decreased cost. While this study focuses on the
application of ChIP-seq in H. salinarum sp.
NRC-1, our workflow can also be adapted for use
in other archaea and bacteria with basic genetic
tools.
INTRODUCTION
The dynamic modulation of gene expression is an import-
ant mechanism that allows organisms to sense and
respond to changes in their environment. These changes
in expression profiles are mediated by dynamic associ-
ations of transcription factors and their cognate regula-
tory regions, collectively known as gene-regulatory
networks (GRNs) (1). Regulatory networks integrate
complex cellular and environmental cues, orchestrating
intricate phenotypes essential for physiology and develop-
ment. The evolutionary rewiring of these regulatory
circuits is thought to be an important driver of speciation
(2). Elucidating the structure and function of GRNs is
therefore a major research initiative in functional
genomics and systems biology (3–8).
The characterization of GRN architecture has been
driven by advances in experimental and computational
methods for identifying genome-wide protein–DNA inter-
actions (9–13). One such approach is chromatin
immunoprecipitation (IP) coupled with high-throughput
sequencing (ChIP-seq), a method that provides quantita-
tive genome-wide mapping of target protein-binding
events. ChIP-seq identifies protein-binding sites with
improved spatial resolution and decreased cost relative
to previous microarray-based ChIP-chip technologies
(10). While ChIP-seq has become a widely used tool in
eukaryotic systems, this method has been applied only
once in a bacterial system (14) and there exist no instances
of such work in archaea. The small size of bacterial and
archaeal genomes makes this high-throughput sequence
technology particularly attractive, as sample multiplexing
can be used to dramatically reduce costs relative to
microarray-based platforms.
Developing a ChIP-seq protocol for archaea would
stimulate high-throughput characterization of GRNs,
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which are a nascent area of study relative to work in the
other two domains of life. Archaea are essential drivers of
global biogeochemical cycling, integral players in indus-
trial applications and biomedically important organisms.
Furthermore, the transcriptional apparatus of archaea
exhibits properties of both eukaryotic and bacterial
systems, making it an intriguing target for investigating
basic principles of regulatory mechanisms across the tree
of life (15). Improved understanding of archaeal informa-
tion processing and transcriptional regulation has wide-
spread applicability.
We present a novel ChIP-seq workflow for the archaea
using the model organism Halobacterium salinarum sp.
NRC-1 (Hb. NRC-1) and demonstrate its application for
mapping the genome-wide binding sites of natively ex-
pressed transcription factors. Previous bacterial and
archaeal ChIP methods have taken different approaches
involving either costly protein-specific antibodies against
native proteins (14) or a standard antibody against
epitope-tagged target proteins that are constitutively
overexpressed from a heterologous plasmid (16,17). This
protocol combines these methods by employing a single,
commercially available antihemagglutinin (HA) antibody
against natively expressed recombinant target proteins.
This ChIP-seq method maintains sensitivity and specifi-
city with as little as 1ml of the typical bacterial or
archaeal culture, making it suitable for high-throughput
analyses. Multiplexing of samples during sequencing sig-
nificantly decreases experimental costs relative to previous
ChIP-chip methods, without diminishing sensitivity and
specificity.
A complimentary bioinformatics method is presented
for user-friendly identification of binding events using
the Pique python package. Integration with the Gaggle
toolkit streamlines the exploration and analysis of
putative protein-binding sites (18,19). This end-to-end
workflow for ChIP-seq of natively expressed proteins
provides a suitable platform for large-scale studies of the
structure and dynamic remodeling of GRNs. The first
protocol of its kind for archaea, this method can be
adapted for work in all bacteria and archaea with
suitable genetic tools.
MATERIALS AND METHODS
Construction of the pRSK01 ligation-independent cloning
vector for Halobacterium salinarum NRC-1
The plasmid pNBK07 (obtained from N. Baliga, Institute
for Systems Biology, Seattle, WA) has been previously
used to create targeted gene knockouts (17,20–22) in the
Hb. NRC-1 pyrF uracil auxotroph strain (Hb. NRC-1
pyrF). For this study, pNBK07 was modified to facilitate
Gateway ligation-independent cloning of segments of
DNA suitable for chromosomal modification by homolo-
gous recombination. Plasmid pNBK07 (sequence and
maps in Supplementary Information) was digested with
StuI (New England Biolabs cat. #R0187S, Ipswitch,
MA), a blunt-end cutting restriction endonuclease. The
digested vector was subsequently dephosphorylated
with calf intestinal alkaline phosphates (New England
Biolabs cat. #M0290S) and purified via agarose gel extrac-
tion. PCR primers m13F and m13R (Supplementary
Table S1) were used to amplify a fragment of the
pDONR221 vector containing an attP1 recombination
site, the ccdB gene, a chloramphenicol resistance marker
and an attP2 recombination site. This PCR product was
ligated into the StuI-digested pNBK07 backbone to create
the Gateway (Invitrogen, Carlsbad, CA) compatible
pRSK01 vector. The pRSK01 vector was sequenced
using the pNBK07F, pNBK07R, ccdB500F and
ccdB500B primers. Sequences (plasmid and oligonucleo-
tide) and plasmid maps are provided in Supplementary
Information.
Construction of chromosomally tagged
transcription factors
Chromosomally epitope-tagged transcription factors were
made by way of site-specific homologous recombination in
Hb. NRC-1 pyrF. This method is analogous to that used
for making in-frame gene knockouts using the pNBK07
vector as previously described (22). Two different
approaches were utilized to make the epitope-tagging con-
structs for this study. In the first approach, PCR-mediated
splicing by overlap extension (SOEing) (23) was used to
join two PCR products used to add a sequence encoding
a region 500 bp upstream of the bacteriorhodopsin-
activator protein (bat) stop codon, an HA epitope coding
sequence, a new stop codon and 500 bp downstream of
the bat genomic stop codon. PCR primers are listed in
Supplementary Table S1. This PCR product was cloned
into the StuI site of plasmid pNBK07, which was subse-
quently transformed into strain Hb. NRC-1 pyrF. A
two-step, double-crossover process was followed to
chromosomally insert the HA epitope. First crossover re-
combinants were selected by plating on 2% (w/v) complete
media (CM) agar plates containing 20 mg/ml mevinolin.
Second crossover recombinants were enriched by selecting
on 2%CM agar plates containing 300 mg/ml 5-fluoroorotic
acid (5-FOA). The absence of a functional pyrF gene is
required for survival on 5-FOA, indicating loss of plasmid.
The second method for chromosomal epitope tagging
was used to tag the general transcription factor tfbD. This
method takes advantage of commercial DNA synthesis
technologies and the new Gateway cloning compatible
pRSK01 vector. In this case, a construct consisting of an
attB1 recombination site, 500 bp upstream of the tfbD
stop codon, the sequence encoding an HA epitope tag, a
stop codon, 500 bp downstream of the tfbD chromo-
somal stop codon, and an attB2 recombination site were
directly synthesized by Geneart (Invitrogen, Carlsbad,
CA) and delivered, cloned, in a pANY backbone vector
also encoding an ampicillin-resistance marker. This vector
was used directly in an in vitro recombination reaction
(Gateway cloning, Invitrogen, Carlsbad, CA) with the
pRSK01 vector according to manufacturer’s protocols to
move the synthetic construct into pRSK01. Once the syn-
thetic construct is inserted into pRSK01, the rest of the
tagging procedure is identical to that used for pNBK07-
based tagging. We have also used a combination of
SOEing and Gateway recombination to directly clone
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PCR products, flanked by appropriate attB recombination
sites, directly into pRSK01 (data not shown).
Verification of chromosomal tagging
The insertion of HA epitopes at the C-terminal ends of the
chromosomally encoded bat and tfbD genes was verified
both by PCR and DNA sequencing. The following PCR
reactions summarized in Supplementary Figure S2 were
conducted to verify insertion of the HA epitope.
The initial PCR screen (Reaction 1) verified the
presence of the C-terminally tagged gene of interest in
the cell using a forward primer (ct_gene_of_interest_a_F)
located in the gene and a reverse primer complimentary to
the HA epitope tag’s sequence (HA_epiope_R). PCR
products of the expected size indicate either successful
chromosomal tagging or the presence of residual tagging
vector in the cell.
Recombinant strains were also screened for the presence
of chromosomally encoded pyrF using primers flanking
the chromosomally encoded gene (k_vng167g3_e_F and
k_vng1673g_d_R, Reaction 2). The presence of
chromosomally encoded pyrF yields a 2050 bp PCR
product, while the disrupted pyrF in the Hb. NRC-1
pyrF strain yields a PCR product of 712 bp. Reaction
2 was performed to verify that the pyrF gene from the
plasmid has not reintegrated into the chromosome of the
Hb. NRC-1 pyrF strain.
A second pyrF PCR screening (Reaction 3) was carried
out to confirm that the plasmid carrying the pyrF had been
cured and that pyrF had not recombined into the chromo-
some of theHb. NRC-1pyrF strain. Reaction 3 amplifies
a region from 465 bp upstream of the pyrF stop codon to
70 bp downstream of the pyrF stop codon (primers
k_vng1673g_g_F and k_vng1673g_h_R). This final
reaction yields no product in the Hb. NRC-1 pyrF
strain and its derivatives. In strains that do carry the
pyrF gene, such as wild type Hb. NRC-1, or strains trans-
formed with either the pNBK07 or pRSK01 plasmids, a
535 bp product is formed.
Finally, we screen specifically for plasmid-encoded
copies of the pyrF gene using primers that amplify a
segment of the pyrF encoded by the pNBK07 or
pRSK01 vectors (k_vng1673g_g_F and o_pNBK07_a_R,
Reaction 4). The absence of product confirms that the
plasmid has been cured, when the reaction is run in con-
junction with plasmid-containing positive control.
PCR products derived from PCR reaction using primers
ct_gene_of_interest_a_F and ct_gene_of_interest_d_R on
strains meeting all the criteria established by the verifica-
tion Reactions 1–4 above were sequenced via standard
Sanger sequencing to verify the integration of the HA
epitope. Sequences are provided in the Supplementary
Information. Tag integration was further verified by
analyzing the genome re-sequencing data for each strain
that was generated in the process of the ChIP-seq
experiment.
Culture preparation
All cultures were grown in the standard CM for
H. salinarum (250 g/l NaCl, 20 g/l MgSO4, 2 g/l KCl,
3 g/L Na–Citrate, 10 g/l Oxoid peptone (Oxoid cat#
LP0034) (Oxoid, Basingstoke, UK) supplemented with
50mg/l uracil and filled to volume with distilled water.
Cultures were revived from 80C freezer stocks and
were streaked on agar plates. Starter cultures were
inoculated from individual colonies and allowed to reach
an optical density at 600 nm of 0.7 before inoculating a
culture at a starting optical density at 600 nm of 0.03. Cells
were grown under ambient light conditions in unbaffled
flasks in a volume equal to 25% of the flask’s maximum
volume. All cultures were grown at 37 ˚ C and shaken at
150 rpm on a New Brunswick G-53 orbital shaker (New
Brunswick, Edison, NJ).
Immunoprecipitation
Biological replicates were conducted as inoculations in
separate but identical volumes on the same orbital
shaker. Cells were harvested at an OD 600 between 0.9
and 1.0, which corresponds to early stationary phase for
Hb. NRC-1. Cells were immediately fixed with 1% (v/v)
formaldehyde for 10min. Fixing was stopped through the
addition of glycine to a final concentration of 125mM.
Batches of 1.75 1010 cells were removed and pelleted at
5000 g. Cell pellets were washed twice with citrate-free
basal salts, after which the pellets were frozen at 80C.
Though this was our standard input for the IP reaction,
we also examined the effect of decreasing the number of
input cells for the IP reaction using the tfbD::HA strain. In
addition to 1.75 1010 cells, these scaling experiments also
used 8.75 109, 3.50 109, 1.75 109 and 3.50 108 cells
as input material for IP. The rest of the method is
described in detail for 1.75 1010 cells. Appropriate
volumes and quantities of reagents for the scaled-down
experiments are reported in Supplementary Table S3.
Cell pellets were resuspended in 1.6ml of lysis buffer
(50mM HEPES, 140mM NaCl, 1mM EDTA, 1% (v/v)
Triton X-100, 0.1% (w/v) sodium deoxycholate, pH 7.5)
containing protease inhibitors (Roche cat# 04693159001).
Resuspended pellets were sonicated using a Bioruptor
(Diagenode, Denville, NJ) until DNA fragment size
reached an average of 500 bp (2–7.5-min cycles, 30 s
on/30 s off, high power setting).
Cell lysate was combined with 1 mg of anti-HA antibody
(Abcam cat# ab9110) (Abcam, Cambridge, MA) and
protein A-conjugated Dynabeads (Invitrogen cat. #
100.2D) preblocked with 5mg/ml BSA in phosphate-
buffered saline and incubated overnight at 4C.
Dynabeads were washed two times with the lysis buffer,
two times with 1ml of the lysis buffer supplemented
with 500mM NaCl, two times with 1ml wash buffer
(10mM Tris, 250mM LiCl, 0.5% NP-40 (v/v), 0.5%
Na-deoxycholate (w/v), 1mM EDTA, pH 8.0) and one
time with 1ml TE buffer. Enriched ChIP DNA/transcrip-
tion factor complexes were eluted by the addition of 50 ml
elution buffer (50mM Tris, 10mM EDTA, 1% SDS
(w/v), pH 8.0) and incubation at 65C for 10min.
Cross-links were reversed by incubating in TE/SDS
(10mM Tris, 1mM EDTA, 1% SDS) overnight at 65C.
RNA was digested and DNA sample was subsequently
prepared for Illumina single read sequencing.
PAGE 3 OF 11 Nucleic Acids Research, 2012, Vol. 40, No. 10 e74
ChIP-seq library preparation
Individual ChIP samples were blunt ended with T4 DNA
polymerase (NEB cat. # M0203L), Klenow large fragment
(NEB cat. # M0210L) and T4 polynucleotide kinase (NEB
cat. # M0201L) at 20C for 30min. Blunt-ended DNA was
30 A tailed with 30->50 exo- Klenow fragment (NEB cat. #
M0212L) for 30min at 37C. Adapters containing 6 bp
barcodes were ligated to the prepared ChIP DNA
samples for 15min at room temperature with T4 DNA
ligase (Enzymatics cat. # L603-HC-L). Barcode sequences
are provided Supplementary Table S4. A background
control of whole cell extract genomic DNA from each
sample was prepared as mentioned above. Samples were
then used as template for an 18-cycle PCR amplification.
PCR products were quantified and visualized with a
high-sensitivity DNA chip (Agilent cat. # 5067-4626) on
a bioanalyzer (Agilent, Santa Clara, CA). ChIP and back-
ground libraries were pooled in equimolar concentrations
and loaded onto a single Illumina lane.
Western blotting
Transcription factors were immunoprecipitated under the
same conditions as ChIP methods mentioned above. IP
samples were run in one dimension on 4–12%, 1.5mm
polyacrylamide gel (Invitrogen cat. # NP0335) in MOPS
buffer (Invitrogen cat. # NP0001). Protein was then
blotted onto a 0.2 -mm pore size PVDF membrane
(Invitrogen cat. # LC2002) at 30V for one hour in
transfer buffer (25mM Tris, 192mM glycine, 10% (v/v)
methanol, pH 8.4). PVDF was blocked in 0.5% (w/v)
casein overnight and subsequently probed with HRP-
conjugated anti-HA antibody (Abcam cat. # ab1265).
The blot was incubated with GE ECL plus reagents
(Amersham cat. # RPN2132) according to the manufac-
turer’s suggestions and exposed to light-sensitive film.
qPCR verification
qPCR was performed on a Bio-Rad Chromo 4 Real-Time
Detector (Bio-Rad, Hercules, CA) using KAPA SYBR
FAST Universal 2 qPCR master mix (Kapa Biosystems
cat.# KK4601) (Kapa Biosystems, Woburn, MA) accord-
ing to the supplied protocol. Primer sets for enriched
regions and negative regions were designed using
known enriched sites and unenriched sites, respectively,
from previous ChIP-seq and ChIP-chip data (see
Supplementary Table S1 for primer sequences). Fold en-
richment above background was calculated as 2 to the
power of cycle threshold difference between a
non-enriched region and an expected enriched site. WCE
extract, ChIP samples and amplified libraries were all used
as template for a qPCR reaction. These were all confirmed
by comparing to a set of ChIP-control reactions on the Hb
NRC-1 pyrF strain.
Sequencing, processing and ChIP-seq peak calling
Multiplexed samples were sequenced to 40 bp on the
Illumina GA-II. Sequences were barcode sorted and
quality trimmed (minimum Phred quality 20, minimum
length 25 bp) using the FASTX-Toolkit (http://
hannonlab.cshl.edu/fastx_toolkit/) (Gordon,A and
Hannon,G.J., unpublished results). Sequencing primer
and adapter contamination were filtered using the
TagDust package (24). Quality-filtered reads were
mapped using Bowtie (25) to the Hb. NRC-1 reference
genome with repeat sequences masked, and SAM format
sequence files were converted to sorted BAM files using
the samtools package (26).
Putative protein–DNA binding events were detected
using Pique, a novel microbially focused and freely
available peak calling application (available at https://
github.com/ryneches/pique, version tag: halo_egw)
(Neches,R.Y., Wilbanks,E.G. and Facciotti,M.T., in
preparation). Pique is written in Python and makes use
of the SciPy signal-processing subroutines (27). Pique is
able to operate on systems that have genomic complexities
such as IS elements, gene dosage polymorphisms and ac-
cessory genomes that cause coverage variations unrelated
to ChIP, or in cases where the organism under study is not
identical to the reference genome. The resulting enrich-
ment ‘pedestals’ and ‘holes’ can be problematic for accur-
ately detecting binding events and calculating enrichment
levels. Hb. NRC-1 has several IS elements and two
plasmids that exhibit dosage variations, and so a seg-
mented analysis was performed by providing a genomic
map of these features in the reference genome.
ChIP-seq coverage data and candidate peaks were
visualized using the Gaggle Genome Browser (18).
Shared peaks were assessed using a combination of
BEDTools (28) and custom R scripts. To assess the
required sequencing depth for accurate and sensitive
binding site identification, random subsampling of a
6 million read TfbD ChIP and WCE control runs were
performed.
RESULTS
Epitope-tagged strain construction
We developed a protocol for rapidly engineering the
strains of the Hb. NRC-1 with epitope-tagged target
proteins under the control of their native promoters.
Using different classes of transcription factors, we demon-
strate this approach’s application and utility. In bacteria
and archaea, different transcription factors may bind a
wide span of target sites, ranging from one to hundreds.
We chose to collect localization data from two extreme
cases. The general transcription factor TfbD is known to
bind hundreds of promoters (16). As an example of a
specific regulator of a smaller regulon, we examined the
Bat transcription factor. This transcription factor pre-
dicted to bind up to four potential sites and is one of
the few haloarchaeal transcription factors with a
well-described binding motif (29).
Our epitope-tagging protocol for Hb. NRC-1 employed
a homologous recombination method analogous to the
gene deletion strategy developed by Peck et al. (30). This
epitope knock-in strategy was described by Zhang et al.
for ChIP-chip applications in human somatic cell lines
(31). For tfbD::HA strain construction, the novel
vector pRSK01, which is compatible with Gateway
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ligation-independent cloning (Invitrogen, Carlsbad, CA),
was created to facilitate and further standardize strain
construction. This new vector allowed the use of either
commercial DNA synthesis technology or PCR-mediated
SOEing (23) with Gateway compatible primers to rapidly
construct the vectors used for strain construction. While in
most instances PCR SOEing is still less expensive, the
decreasing cost of DNA synthesis should make this
approach a more attractive alternative for future
large-scale strain construction projects.
Hb. NRC-1 pyrF was transformed with a recombinant
plasmid that contained the terminal 500 bp of the target
gene, a hemagglutinin (HA) tag, stop codon and 500 bp
downstream sequence (Figure 1). Homologous recombin-
ation between the chromosomal target gene and the re-
combinant plasmid sequence introduced the HA tag to
the chromosomal sequence. Successful first recombinants
were determined by PCR screening of MevR colonies
(Supplementary Figure S1). The plasmid was subsequently
resolved using 5-FOA counter-selection as previously
described (22,30). Strains with C-terminally HA-tagged
target proteins were further verified by PCR and Sanger
sequencing (Supplementary Figures S1–S2 and
Supplementary Information). For the rapid construction
of epitope-tagged transcription factor strains, this general
strategy of utilizing DNA synthesis and homologous
recombination-based chromosomal modification can be
readily extended to any organisms with a system for
targeted genetic knockouts.
Western blotting with anti-HA antibody confirmed
the specificity of the ChIP assay in these chromosomally
tagged strains (Supplementary Figure S3). The
chromosomally integrated, epitope-tagged proteins
remain under the control of their native promoters, as
observed in the differential expression of the TfbD-HA
protein over the course of growth in the recombinant
strain pyrF tfbD::HA (Supplementary Figure S4).
Increase in the abundance of TfbD during stationary
phase is consistent with previous reports of tfbD transcrip-
tional abundance (20). This approach can be used to
monitor dynamic changes in the GRN that occur under
different physiological conditions.
Identifying target protein DNA-binding sites
We used ChIP-seq to analyze with two different classes of
target proteins: the general transcription factor TfbD and
the Bat using recombinant strains that natively express the
target protein (pyrF bat::HA and pyrF tfbD::HA).
From the ChIP-seq datasets of 1.2 million reads for each
factor, we identified 380 binding sites for TfbD and two
binding sites for Bat (the brp and crtB1 promoters).
These punctate target protein DNA-binding events
produce a distinctive bimodal, strand-specific enrichment
pattern in sequence coverage (Figure 2). This enrichment
pattern was leveraged to identify binding sites using our
open source software package Pique, which reports the
candidate binding site’s enrichment as the ratio of
sequence coverage in the IP data relative to a background
control (Neches,R.Y., Wilbanks,E.G. and Facciotti,M.T.,
in preparation). Pique is implemented from a user-friendly
graphical user interface and exports predicted binding
sites to the Gaggle Genome Browser (18). From the
Gaggle genome browser, users can explore and curate
the data before proceeding with analysis via other down-
stream Gaggle tools (Figure 3).
To confirm the specificity of the HA antibody for the
ChIP assay on the recombinant HA-tagged strains, we
conducted ChIP-seq on the pyrF parent strain where
no HA tags were expressed. The data contained a single
peak, at chromosomal position 166589, likely because of
the presence of a similar epitope in a native protein. This
peak was present in all datasets examined and was subse-
quently filtered from all downstream analysis.
HA
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Figure 1. Epitope tag-in approach for Hb. NRC-1. The Hb. NRC-1
pyrF strain is transformed with a plasmid containing the
mevinolin-resistance determinant (MevR; dark gray box) and the pyrF
gene (black box) that confers 5-FOA sensitivity. The plasmid carries an
engineered sequence containing the HA epitope sequence (white box)
flanked by the last 500 bp of the target gene and the 500 bp downstream
of the target gene (light gray boxes). Plasmid sequence is shown as solid
line, chromosomal sequence is shown as solid, wavy lines. Cross-over
can occur between target gene (light gray box) and flanking sequence
(gray wavy line) in the chromosome and the homologous regions in the
plasmid sequence, at either position 1 or 2 (position 1 example shown).
PCR screening of mevinolin-resistant colonies is used to determine suc-
cessful first recombinants. Subsequent plating on 5-FOA selects for
second recombinants (via counter-selection with the pyrF gene). In
this example, a second cross-over at site 2 produces the desired
chromosomally integrated recombinant target_gene::HA fusion.
PCR screening of these colonies is required to distinguish this
desired second recombinant from a second recombinant occurring at
position 1. Drawing is not to scale.
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Independent biological replicates of the TfbD ChIP-seq
experiment showed good reproducibility (82%
overlapping binding sites). Differences between the two
replicates are due to the smallest peaks in each dataset,
as indicated by examining increasingly stringent enrich-
ment thresholds (Supplementary Figure S5). Both
binding sites in the Bat dataset and two example sites in
the TfbD datasets (VNG906H and atp_p promoters) were
confirmed with a ChIP-qPCR assay. The relationship
between the quantification of ChIP enrichment at the
binding sites determined by qPCR and sequencing was
found to be well correlated across several experiments
(Figure 4). The TfbD ChIP-seq binding sites agreed well
with previously reported sites from TfbD ChIP-chip ex-
periments (16). For both the ChIP-seq and ChIP-chip
methods, 80% of consensus binding sites from biological
replicates were identified by at least one of the replicates
from the other method.
Spatial resolution
The spatial resolution of the ChIP-seq binding site predic-
tion was assessed for the Bat and TfbD datasets. As the
Bat transcription factor has a well-characterized predicted
binding motif (29), we used the distance from our pre-
dicted binding site to the motif center as an estimate of
the spatial resolution. The binding sites at the brp and
crtB1 promoters were found, respectively, at 20 and
27 bp upstream of the predicted Bat-binding motif center
(30 displaced).
As there exists no well-defined binding motif for the
general transcription factor TfbD, we used proximity to
the nearest predicted transcript start site (TSS) as a
measure of spatial resolution for this factor. Archaeal
TFB proteins, homologs of the eukaryotic factor TFIIB,
canonically bind at B-recognition elements 30–50 bp
upstream of the TSS, in association with a
TATA-binding protein (32). Eighty-six percent of the
312 consensus binding sites from the TfbD ChIP-seq bio-
logical replicates were found within 250 bp of a predicted
TSS (in either 30 or 50 direction). We measured the distance
from each of these predicted binding sites to the nearest
predicted TSS. These values were compared to the
distance to TSS from previously reported TfbD
ChIP-chip sites, determined with both 500-bp contiguous
and 12-bp overlapped tiling microarray (Figure 5) (16).
The distance to TSS for the ChIP-seq binding sites
(median=32, mean=51) is in agreement with the
expected binding pattern for this general transcription
factor, and is significantly smaller than that predicted by
both resolutions of ChIP-chip microarray (Mann Whitney
U-test, p value< 0.005). The variance in these distance
measurements provides an estimate of the precision with
which each method maps binding sites. The ChIP-seq
dataset has significantly decreased variance relative
to both ChIP-chip datasets (significance assessed
by Bartlett test, p value< 0.005; samples were tested
for normality by two-sided Kolmogorov-Smirnov
p value< 0.0005). Taken together, these data indicate
that the ChIP-seq assay offers improved spatial resolution
in mapping the target protein-binding site relative to prior
ChIP-chip assays.
ChIP assay cell number and sequencing depth
We investigated the number of cells required for ChIP to
produce sufficient enrichment at target protein-binding
sites. Decreasing the number of cells in the ChIP
reaction lowered the observed enrichment at target
protein-binding sites; however, enrichment (>5 x) was de-
tectable for highly enriched TfbD-binding sites when as
few as 3.50 108 cells were used for ChIP, equivalent to
1 ml of a typical culture (Figure 6A). Because of the
overall decrease in enrichment, smaller cell number
ChIPs were less sensitive in binding site detection but
maintained specificity (Figure 6B). The relatively small
volume required for this ChIP assay should enable the
high-throughput application of this method in the
context of dynamic binding studies by allowing for
the repetitive sampling of numerous strains with minimal
perturbation.
One of the main advantages to the ChIP-seq platform
for small microbial genomes is the ability to decrease the
experimental cost by multiplexing many samples in a
single sequencing lane. We carried out an in silico
analysis to determine the depth of sequencing necessary
to achieve sensitive and accurate detection of binding
sites. Sequence reads were randomly subsampled
to decreasing coverage levels from 1.2M reads
5’
3’
3’
5’
Sense strand
ChIP enriched fragments
sequence read
}
Antisense strand
ChIP enriched fragments
antisense coveragesense coverage
align to
reference genome
Figure 2. The 50 to 30 sequencing requirement and short read length
produce stranded bias in sequence coverage. The shaded blue oval rep-
resents the protein of interest bound to DNA (solid black lines). Wavy
lines represent either sense (blue) or antisense (red) DNA fragments
from ChIP enrichment. The thicker portion of the line indicates
regions sequenced by short read sequencing technologies. Sequenced
tags are aligned to a reference genome and shown below is the
strand-specific sequence coverage at each position in the genome.
Punctate-binding events (e.g. transcription factors) are characterized
by well-defined strand-specific bimodality in sequence coverage.
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(15.4 x coverage) to 10 000 reads (0.13 x coverage). For the
TfbD dataset, the number of peaks identified remained
stable down to 500K reads (5 x coverage), after which
the sensitivity began to decrease (Figure 7). The specificity
of binding site identification remained excellent below
500K reads, even though the sensitivity decreased
(Figure 7).
For the Bat dataset, the more strongly enriched binding
site at the brp promoter could be detected in datasets as
small as 50 000 reads (0.64 x coverage), whereas the
weaker binding at the crtB1 promoter was undetectable
below 150 000 reads (1.9 x coverage). No false positives
were detected in these lower coverage datasets, with the
exception of a single site in the 200 000 read dataset.
Examining the effect of decreased coverage on the
spatial resolution, we found that the automated prediction
of the binding site remained accurate, until just before the
site became undetectable (Figure 8).
DISCUSSION
We report here a workflow for the genome-wide
mapping of archaeal natively expressed transcription
factors using a standardized, cost-effective, high-
throughput ChIP-seq platform. This is the first example
of a ChIP-seq protocol for archaea. The development of
FireGoose
Database Queries
Boss
Gaggle Genome
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KEGG
NCBI EMBL STRING
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Cytoscape
(networks)
(statistics)
Figure 3. The Pique software package processes ChIP-seq coverage data to predict protein-binding sites. Strand-specific coverage data are output as
tracks for the Gaggle Genome Browser, and putative-binding sites (peaks) are output as ‘bookmark files’. (A) Screenshot of data browsing in the
Gaggle Genome Browser. Green box outlines the navigation window for clicking through bookmarks of predicted binding sites. Details of each site
can be displayed (inset). The Gaggle toolbar (shown with black arrow) can be used to broadcast selected data to other ‘geese’ in the gaggle package,
programs such as R, cytoscape, BLAST or KEGG. (B) Schematic overview of bioinformatics workflow.
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Figure 4. ChIP enrichment of binding sites determined by qPCR and
sequencing show a linear relationship. Data shown are drawn from
multiple ChIP experiments: the Bat ChIP (Pbrp and PcrtB1 closed and
open circles) and the TfbD ChIP and the reduced cell number TfbD
ChIPs (PVNG906H and Patp_p; closed and open triangles). Differences in
enrichment at the TfbD-bound promoters corresponded to changes
produced by decreasing the number of cells in the ChIP reaction (see
Figure 5 for further details).
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Figure 5. Distance from predicted TfbD-binding site for ChIP-seq
(consensus between biological replicates), 500-bp tiling microarray
ChIP-Chip (consensus between biological replicates) and 12-bp tiling
microarray ChIP-Chip experiments. The observed difference in means
was statistically significant (Mann Whitney U-test, p value< 0.005), as
is the observed difference in variance (Bartlett test, p value< 0.005).
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this high-throughput method for mapping protein–DNA
binding events in archaea should catalyze the investigation
of the GRNs in this third domain of life.
While major advances have been made in mapping
the GRNs of bacteria and eukaryotes, the GRNs of
archaea represent a nascent area of exploration, with
only a handful of genome-wide experimental studies
(8,16,17,33,34). Understanding regulatory mechanisms in
archaea will greatly inform our understanding of the basic
biology of this important domain, relevant to diverse fields
of study from biogeochemistry to biotechnology. The de-
velopment of improved methods for surveying archaeal
GRNs is timely, coinciding with a new wave of archaeal
genome sequencing that has suggested many conserved
archaeal regulatory mechanisms (34,35).
Archaea also possess an intriguing mosaic tran-
scriptional apparatus that exhibits properties of both
eukaryotic and bacterial systems. While the basal tran-
scriptional machinery of archaea is homologous to that
of eukaryotes, archaeal transcriptional regulators are
more similar to those of bacteria. Studies of archaeal tran-
scription have provided insight into both the mechanisms
and evolution of information processing in the three
domains of life (32,36). Likewise, deciphering archaeal
GRNs holds a great potential for advancing our under-
standing of fundamental principles employed by GRNs
across the tree of life.
The workflow presented here is cost efficient and
amenable to high-throughput scaling. To increase
throughput and minimize costs, we relied on recombinant
strains with low-profile HA epitope-tagged target proteins
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from ChIPseq predicted binding site to nearest Bat-binding motif was
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Figure 7. Subsampling sequence coverage. Sequences were randomly
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and a standard anti-HA antibody for the ChIP assay. The
HA epitope tag in conjunction with the well-characterized
commercial antibody proved efficient for IP while minim-
ally perturbing the target protein. The choice of the ster-
ically slim HA epitope tag can prove quite important; we
have found that the larger repeated myc epitope tag (37)
can render some DNA-binding proteins nonfunctional.
The HA tag does not disrupt Bat function, as seen in its
ability to complement a bat knockout mutation and
induce bacteriorhodopsin production (Supplementary
Figure S6).
A transcription factor’s occupancy of possible binding
sites depends, in part, on its concentration within the cell.
As our ultimate goal is to map the dynamics of regulatory
network rearrangement, native expression of the target
transcription factor, rather than constitutive expression
from a plasmid construct, was an important feature of
our approach. To accomplish this, we used recombinant
target proteins that were chromosomally integrated under
the control of the wild-type promoter. The construction of
these recombinant archaeal strains required the develop-
ment of a method for generating chromosomally
integrated recombinant proteins in Hb. NRC-1, thereby
expanding the genetic toolbox available for this model
archaeon.
Previous ChIP-chip studies in Hb. NRC-1 used target
proteins that were constitutively expressed at nonnative
levels from a heterologous plasmid (16,33,38). The result-
ant protein–DNA associations are, therefore, perhaps best
viewed as lists of all possible interactions rather than a
snapshot of protein–DNA association network under
physiological conditions. While this approach is appropri-
ate for some applications and can offer technical advan-
tages, such as improving ChIP efficiency for proteins
present in low abundance, expression of target proteins
at nonnative levels can produce artifacts in the list of
protein-–DNA binding sites. In the simplest case, consti-
tutive overexpression can drive transcription factor asso-
ciation to weak or nonspecific sites without significantly
perturbing expression. Ambiguities concerning which
binding sites are physiologically relevant can sometimes
be resolved by incorporating data such as transcriptomes
and regulatory motifs in the analysis. However, the per-
turbation of transcription factor expression can also have
more serious consequences that cannot be easily resolved,
such as unintended protein–protein interactions and
changes in the cellular phenotype. Lastly, constitutive
nonnative expression precludes investigating the
dynamics of transcription factor association, a fundamen-
tal aspect in understanding the relationship between the
GRN structure and function.
We demonstrated the application of our ChIP-seq
protocol on two different classes of archaeal transcription
factor: a general transcription factor with many binding
sites (TfbD) and a more specific transcriptional activator
(Bat). ChIP-seq data were analyzed with the user-friendly,
open-source Pique package, designed for identifying
protein–DNA binding events in small bacterial and
archaeal genomes. Our bioinformatics pipeline integrates
with the Gaggle toolkit to facilitate downstream data visu-
alization, curation and analysis.
The predicted binding sites were consistent between bio-
logical replicates and with previously published ChIP-chip
results for TfbD. We observed few significant trends in
the gene classes bound by TfbD, with the exception of
gene functionally associated with GTPase activity
(p value=1 104). The lack of obvious functional par-
titioning of TfbD target genes is unsurprising, given this
factor’s broad role in global transcription initiation.
Dynamic ChIP-seq experiments under different physio-
logical conditions would likely be an appropriate future
method for determining the potential regulatory roles
carried out by TfbD and other archaeal general transcrip-
tion factors.
The two Bat-binding sites discovered in the brp and
crtB1 promoters (Pbrp, and PcrtB1) were verified by qPCR
and contain two of the four previously reported
occurrences of the Bat regulatory motif (Pbop and Pblp
were not bound) (29). It seems initially surprising that
Bat binding was not detected upstream of the
bacteriorhodopsin apoprotein (bop), a gene it regulates
(29,39–41). However, recent research has shown that Bat
regulation of bop expression is complex and may work
cooperatively with accessory proteins Brz and Brb (42,43).
Interestingly, the Bat-binding motif at Pbrp, and PcrtB1
share a single nucleotide insertion relative to the two
unbound motif sites at Pbop and Pblp. Furthermore, the
spacer sequence between the Bat motif and the
TATA-box is shorter at Pbrp and PcrtB1 sites (2 and 3 bp
spacer, respectively), relative to the unbound Pbop and Pblp
motif occurrences (5 bp spacer) (29). We note that these
small differences in the Bat motif, in concert with our
binding data, may provide some preliminary evidence to
suggest a way by which Bat (and potential coregulators)
distinguishes between the four predicted binding sites in a
condition-specific manner.
ChIP-seq identifies protein-binding sites with fine
spatial resolution and provides accurate estimates of
binding site enrichment. The quantification of enrichment
found at protein binding sites calculated by ChIP-seq was
very similar to that determined by ChIP-qPCR (Figure 5).
Unlike ChIP-chip enrichment values, which become
saturated at high levels of enrichment, ChIP-seq has ex-
cellent dynamic range, and thus provides an accurate
metric for the level of enrichment at target protein-binding
sites. A narrow size selection of chromatin immunopre-
cipitated DNA fragments enhances the enrichment in
sequence coverage at target-binding sites. The use of auto-
mated size-selection instruments, such as the Pippin Prep
(Sage Science, Beverly, MA), in the preparation of
ChIP-seq libraries may improve data quality.
The number of cells required for the ChIP assay was
investigated to determine an optimal protocol that
balances sensitivity of binding site detection with through-
put and ease of sample handling. Decreasing the number
of cells for the ChIP assay was found to decrease the en-
richment level at target protein-binding sites, and thus the
sensitivity of the assay. However, the more strongly
enriched sites could still be accurately detected with
3.50 108 cells, equivalent to 1ml of a typical culture.
The false-positive rate remains very low in the lower cell
number ChIP-seq experiments. The ability to use low cell
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counts as input makes this approach tractable for
high-throughput assessment of the more prominent
binding sites in the genome, though precludes develop-
ment of an exhaustive list of possible protein–DNA
interactions.
By randomly subsampling deeply sequenced datasets,
we determined that the required sequence coverage for
the sensitive detection of binding sites corresponds to
6.5 x coverage of the complete genome (approximately
500K reads in Hb. NRC-1). We estimate that for the aver-
age sequencing run on the Illumina HiSeq (80 million
reads) and the typical bacterial and archaeal genome
(3Mb), 130 samples can be multiplexed per lane. With
this level of multiplexing, the ChIP-seq assay would cost
roughly $15 per sample. The per-sample cost is expected
to drop even further with continuing improvements in
the output of sequencing technologies. Relative to
ChIP-chip, this ChIP-seq workflow greatly reduces the
experimental cost of defining the genome-wide binding
sites of target transcription factors while also improving
spatial resolution. From gene tagging to data analysis, this
workflow provides an excellent model for conducting
large-scale, dynamic mapping of bacterial and archaeal
gene regulator networks.
ACCESSION NUMBERS
All high-throughput sequencing data generated in this
work are available via BioTorrents (http://www
.biotorrents.net/details.php?id=259) or from our lab
website (www.bme.ucdavis.edu/facciotti/resources_data/
data/). The open access Pique package and source code
can be obtained via github at https://github.com/ryneches/
pique. Primer and plasmid sequences used in this study are
available in Supplementary Information.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR
Online: Supplementary Tables 1–4, Supplementary
Figures 1–6, Supplementary Information and Supple-
mentary Reference (44).
FUNDING
UC Davis Startup Funds to M.T.F., an NSF GRFP to
E.G.W. and DARPA award (HR0011-05-1-0057) to
R.Y.N. Funding for open access charge: UC Davis
Startup Funds to M.T.F.
Conflict of interest statement. None declared.
REFERENCES
1. Davidson,E.H. (2001) Genomic Regulatory Systems: Development
and Evolution. Academic Press, San Diego.
2. Shou,C., Bhardwaj,N., Lam,H.Y., Yan,K.K., Kim,P.M.,
Snyder,M. and Gerstein,M.B. (2011) Measuring the evolutionary
rewiring of biological networks. PLoS Comput. Biol., 7, e1001050.
3. Harbison,C.T., Gordon,D.B., Lee,T.I., Rinaldi,N.J.,
Macisaac,K.D., Danford,T.W., Hannett,N.M., Tagne,J.B.,
Reynolds,D.B., Yoo,J. et al. (2004) Transcriptional regulatory
code of a eukaryotic genome. Nature, 431, 99–104.
4. Peter,I.S. and Davidson,E.H. (2009) Modularity and design
principles in the sea urchin embryo gene regulatory network.
FEBS Lett., 583, 3948–58.
5. Kaleta,C., Gohler,A., Schuster,S., Jahreis,K., Guthke,R. and
Nikolajewa,S. (2010) Integrative inference of gene-regulatory
networks in Escherichia coli using information theoretic concepts
and sequence analysis. BMC Syst. Biol., 4, 116.
6. Palaniswamy,S.K., James,S., Sun,H., Lamb,R.S., Davuluri,R.V.
and Grotewold,E. (2006) AGRIS and AtRegNet. a platform to
link cis-regulatory elements and transcription factors into
regulatory networks. Plant Physiol., 140, 818–29.
7. Fadda,A., Fierro,A.C., Lemmens,K., Monsieurs,P., Engelen,K.
and Marchal,K. (2009) Inferring the transcriptional network of
Bacillus subtilis. Mol. Biosyst., 5, 1840–52.
8. Bonneau,R., Facciotti,M.T., Reiss,D.J., Schmid,A.K., Pan,M.,
Kaur,A., Thorsson,V., Shannon,P., Johnson,M.H., Bare,J.C. et al.
(2007) A predictive model for transcriptional control of
physiology in a free living cell. Cell, 131, 1354–65.
9. Hesselberth,J.R., Chen,X., Zhang,Z., Sabo,P.J., Sandstrom,R.,
Reynolds,A.P., Thurman,R.E., Neph,S., Kuehn,M.S., Noble,W.S.
et al. (2009) Global mapping of protein–DNA interactions in vivo
by digital genomic footprinting. Nat. Methods, 6, 283–89.
10. Park,P.J. (2009) ChIP-seq: advantages and challenges of a
maturing technology. Nat. Rev. Genet., 10, 669–80.
11. Wilbanks,E.G. and Facciotti,M.T. (2010) Evaluation of algorithm
performance in ChIP-seq peak detection. PLoS One, 5, e11471.
12. Bonneau,R., Reiss,D.J., Shannon,P., Facciotti,M., Hood,L.,
Baliga,N.S. and Thorsson,V. (2006) The Inferelator: an algorithm
for learning parsimonious regulatory networks from
systems-biology data sets de novo. Genome Biol., 7, R36.
13. de Jong,H. (2002) Modeling and simulation of genetic regulatory
systems: a literature review. J. Comput. Biol., 9, 67–103.
14. Lun,D.S., Sherrid,A., Weiner,B., Sherman,D.R. and Galagan,J.E.
(2009) A blind deconvolution approach to high-resolution
mapping of transcription factor binding sites from ChIP-seq data.
Genome Biol., 10, R142.
15. Bell,S.D. (2005) Archaeal transcriptional regulation—variation on
a bacterial theme? Trends Microbiol., 13, 262–265.
16. Facciotti,M.T., Reiss,D.J., Pan,M., Kaur,A., Vuthoori,M.,
Bonneau,R., Shannon,P., Srivastava,A., Donohoe,S.M.,
Hood,L.E. et al. (2007) General transcription factor specified
global gene regulation in archaea. Proc. Natl Acad. Sci USA, 104,
4630–35.
17. Kaur,A., Van,P.T., Busch,C.R., Robinson,C.K., Pan,M.,
Pang,W.L., Reiss,D.J., DiRuggiero,J. and Baliga,N.S. (2010)
Coordination of frontline defense mechanisms under severe
oxidative stress. Mol. Syst. Biol., 6, 393.
18. Bare,J.C., Koide,T., Reiss,D.J., Tenenbaum,D. and Baliga,N.S.
(2010) Integration and visualization of systems biology data in
context of the genome. BMC Bioinformatics, 11, 382.
19. Shannon,P.T., Reiss,D.J., Bonneau,R. and Baliga,N.S. (2006)
The Gaggle: an open-source software system for integrating
bioinformatics software and data sources. BMC Bioinformatics, 7,
176.
20. Facciotti,M.T., Pang,W.L., Lo,F.Y., Whitehead,K., Koide,T.,
Masumura,K., Pan,M., Kaur,A., Larsen,D.J., Reiss,D.J. et al.
(2010) Large-scale physiological readjustment during growth
enables rapid, comprehensive and inexpensive systems analysis.
BMC Syst. Biol., 4, 64.
21. Schmid,A.K., Reiss,D.J., Kaur,A., Pan,M., King,N., Van,P.T.,
Hohmann,L., Martin,D.B. and Baliga,N.S. (2007) The anatomy
of microbial cell state transitions in response to oxygen. Genome
Res., 17, 1399–1413.
22. Kaur,A., Pan,M., Meislin,M., Facciotti,M.T., El-Gewely,R. and
Baliga,N.S. (2006) A systems view of haloarchaeal strategies to
withstand stress from transition metals. Genome Res., 16, 841–54.
23. Horton,R.M., Hunt,H.D., Ho,S.N., Pullen,J.K. and Pease,L.R.
(1989) Engineering hybrid genes without the use of restriction
enzymes: gene splicing by overlap extension. Gene, 77, 61–68.
24. Lassmann,T., Hayashizaki,Y. and Daub,C.O. (2009) TagDust—a
program to eliminate artifacts from next generation sequencing
data. Bioinformatics, 25, 2839–40.
e74 Nucleic Acids Research, 2012, Vol. 40, No. 10 PAGE 10 OF 11
25. Langmead,B., Trapnell,C., Pop,M. and Salzberg,S.L. (2009)
Ultrafast and memory-efficient alignment of short DNA
sequences to the human genome. Genome Biol., 10, R25.
26. Li,H., Handsaker,B., Wysoker,A., Fennell,T., Ruan,J., Homer,N.,
Marth,G., Abecasis,G. and Durbin,R. (2009) The sequence
alignment/map format and SAMtools. Bioinformatics, 25,
2078–79.
27. Peterson,P. (2009) F2PY: a tool for connecting Fortran and
Python programs. Int. J. Comput. Sci. Eng., 4, 296–305.
28. Quinlan,A.R. and Hall,I.M. (2010) BEDTools: a flexible suite of
utilities for comparing genomic features. Bioinformatics, 26,
841–42.
29. Baliga,N.S., Kennedy,S.P., Ng,W.V., Hood,L. and DasSarma,S.
(2001) Genomic and genetic dissection of an archaeal regulon.
Proc. Natl Acad. Sci USA, 98, 2521–25.
30. Peck,R.F., DasSarma,S. and Krebs,M.P. (2000) Homologous gene
knockout in the archaeon Halobacterium salinarum with ura3 as a
counterselectable marker. Mol. Microbiol., 35, 667–76.
31. Zhang,X., Guo,C., Chen,Y., Shulha,H.P., Schnetz,M.P.,
LaFramboise,T., Bartels,C.F., Markowitz,S., Weng,Z.,
Scacheri,P.C. et al. (2008) Epitope tagging of endogenous
proteins for genome-wide ChIP-chip studies. Nat. Methods, 5,
163–65.
32. Bell,S.D. and Jackson,S.P. (1998) Transcription in archaea.
Cold Spring Harb. Symp. Quant. Biol., 63, 41–51.
33. Schmid,A.K., Pan,M., Sharma,K. and Baliga,N.S. (2011) Two
transcription factors are necessary for iron homeostasis in a
salt-dwelling archaeon. Nucleic Acids Res., 39, 2519–33.
34. Yoon,S.H., Reiss,D.J., Bare,J.C., Tenenbaum,D., Pan,M.,
Slagel,J., Moritz,R.L., Lim,S., Hackett,M., Menon,A.L. et al.
(2011) Parallel evolution of transcriptome architecture during
genome reorganization. Genome Res., 21, 1892–1904.
35. Gelfand,M.S., Koonin,E.V. and Mironov,A.A. (2000) Prediction
of transcription regulatory sites in Archaea by a comparative
genomic approach. Nucleic Acids Res., 28, 695–705.
36. Geiduschek,E.P. and Ouhammouch,M. (2005) Archaeal
transcription and its regulators. Mol. Microbiol., 56, 1397–1407.
37. Ren,B., Robert,F., Wyrick,J.J., Aparicio,O., Jennings,E.G.,
Simon,I., Zeitlinger,J., Schreiber,J., Hannett,N., Kanin,E. et al.
(2000) Genome-wide location and function of DNA-binding
proteins. Science, 290, 2306–9.
38. Schmid,A.K., Reiss,D.J., Pan,M., Koide,T. and Baliga,N.S. (2009)
A single transcription factor regulates evolutionarily diverse but
functionally linked metabolic pathways in response to nutrient
availability. Mol. Syst. Biol., 5, 282.
39. Gropp,F. and Betlach,M.C. (1994) The bat gene of
Halobacterium halobium encodes a trans-acting oxygen
inducibility factor. Proc Natl Acad Sci USA, 91, 5475–5479.
40. Leong,D., Pfeifer,F., Boyer,H. and Betlach,M. (1988)
Characterization of a second gene involved in bacterio-opsin gene
expression in a halophilic archaebacterium. J. Bacteriol., 170,
4903–9.
41. Baliga,N.S., Pan,M., Goo,Y.A., Yi,E.C., Goodlett,D.R.,
Dimitrov,K., Shannon,P., Aebersold,R., Ng,W.V. and Hood,L.
(2002) Coordinate regulation of energy transduction modules in
Halobacterium sp. analyzed by a global systems approach.
Proc. Natl Acad. Sci. USA, 99, 14913–18.
42. Tarasov,V.Y., Besir,H., Schwaiger,R., Klee,K., Furtwangler,K.,
Pfeiffer,F. and Oesterhelt,D. (2008) A small protein from the
bop-brp intergenic region of Halobacterium salinarum contains a
zinc finger motif and regulates bop and crtB1 transcription.
Mol. Microbiol., 67, 772–80.
43. Tarasov,V., Schwaiger,R., Furtwangler,K., Dyall-Smith,M. and
Oesterhelt,D. (2011) A small basic protein from the brz-brb
operon is involved in regulation of bop transcription in
Halobacterium salinarum. BMC Mol. Biol., 12, 42.
44. Yang,C.F., Kim,J.M., Molinari,E. and DasSarma,S. (1996)
Genetic and topological analyses of the bop promoter of
Halobacterium halobium: stimulation by DNA supercoiling and
non-B-DNA structure. J. Bacteriol., 178, 840–45.
PAGE 11 OF 11 Nucleic Acids Research, 2012, Vol. 40, No. 10 e74
